Halozyme Therapeutics Inc (NASDAQ:HALO)

18.09
Delayed Data
As of 4:00pm ET
 -0.50 / -2.69%
Today’s Change
11.41
Today|||52-Week Range
21.48
-10.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Torley Helen I
President & Chief Executive Officer
Sale2/03/201824,111$18.37$442.9K+4.67%
Torley Helen I
President & Chief Executive Officer
Sale2/22/201819,511$19.28$376.2K-3.58%
Torley Helen I
President & Chief Executive Officer
Sale2/06/201815,493$18.25$282.7K+1.86%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201811,649$19.46$226.7K-0.69%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/03/20188,265$18.37$151.8K+4.67%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/03/20185,605$18.37$103.0K+4.67%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/22/20183,939$19.28$75.9K-3.58%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/22/20183,939$19.28$75.9K-3.58%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale6/15/20183,254$19.02$61.9K-2.26%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale4/13/20182,377$19.37$46.0K-4.03%
Page of 3